Dorte Strobel is an accomplished professional with extensive experience in regulatory affairs and intelligence, currently serving as Head of Global Regulatory Intelligence at LEO Pharma since January 2019. Prior to this role, Dorte held various senior positions at Novo Nordisk from February 1995 to December 2018, including Senior Regulatory Intelligence Manager, where responsibilities involved analyzing regulatory trends and providing strategic guidance across the organization. Dorte's career also includes significant roles in project management and quality assurance within regulatory affairs, as well as early positions as a pharmacist at multiple institutions. Dorte's educational background includes a Master’s degree in Pharmacy and diplomas in project management and managing medical product innovation. Key areas of expertise encompass process optimization, regulatory strategies, and international collaboration across diverse markets.